Elicio Therapeutics, Inc. ( ELTX) - Key Metrics
ELTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.43 | -$0.42 | -$0.42 |
| 2026Q1 | $0 | -$0.65 | -$0.64 | -$0.64 |
| 2025Q4 | $0 | -$0.50 | -$0.44 | -$0.44 |
| 2025Q3 | $0 | -$0.60 | -$0.66 | -$0.66 |
| 2025Q2 | $0 | -$0.66 | -$0.56 | -$0.56 |
ELTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.27 |
| 2026Q1 | 0% | -4.11 |
| 2025Q4 | 0% | -4.42 |
| 2025Q3 | 0% | -4.56 |
| 2025Q2 | 0% | -2.92 |
ELTX
Price: $3.04
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 81.7 million